LAURA JUDE: Open Payments
NPI 1326641267 · SALINAS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$459 in 21 payments from 11 companies in 2025. Trend: 2023 $2,095 · 2024 $1,200 · 2025 $459
Food & beverage: $459
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 3 | $70 |
| SANOFI-AVENTIS U.S. LLC | 2 | $67 |
| Amgen Inc. | 3 | $56 |
| Lilly USA, LLC | 3 | $54 |
| Novo Nordisk Inc | 2 | $45 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Exact Sciences Corporation | 1 | $33 |
| ABBVIE INC. | 1 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| ViiV Healthcare Company | 1 | $17 |
Products named: Dexcom G6 Transmitter, TZIELD, EVENITY, MOUNJARO, TRELEGY ELLIPTA, The Cologuard Plus Collection Kit, QULIPTA, Ozempic.
Industry payments across CA — which companies pay providers there.
